The Case for Transparency in Peer Review: Enhan...

By João L. Carapinha

June 9, 2025

The purpose of this update is to explore the crucial role of transparency in peer review within the scientific community. The article from the BMJ (linked below) discusses concerns about increasing transparency in the peer review process by making...
Quantifying EU Medicine Access Challenges
Revitalizing Innovation: The Impact of UK Medicine Payment Rates
Blinatumomab Benefit Assessment for ALL and Health Economics
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges
NICE HealthTech Reforms: Accelerating Digital Innovation in NHS and Global He...
Allopurinol Designated an Orphan Drug for Marfan Syndrome
NICE’s Approval of Marstacimab for Hemophilia B: Transforming Treatment...
EU Patent Licensing Framework: Enhancing Crisis Management in the EU
EU Establishes Expert Panel for Orphan Paediatric Devices
High Orphan Drug Prices Persist Despite Market Exclusivity Expiration
Navigating EU AI Act Healthcare Compliance: Proactive Steps for Ethical AI In...
Biosimilars Price Competition: Impact on U.S. Pharmaceutical Pricing and Mark...